These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16113302

  • 21. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y, Granoff DM.
    JAMA; 1992 Mar 18; 267(11):1489-94. PubMed ID: 1538539
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
    Sun X, Stefanetti G, Berti F, Kasper DL.
    Proc Natl Acad Sci U S A; 2019 Jan 02; 116(1):193-198. PubMed ID: 30510007
    [Abstract] [Full Text] [Related]

  • 24. Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines.
    Fattom A, Cho YH, Chu C, Fuller S, Fries L, Naso R.
    Vaccine; 1999 Jan 02; 17(2):126-33. PubMed ID: 9987146
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.
    de Velasco EA, Merkus D, Anderton S, Verheul AF, Lizzio EF, Van der Zee R, Van Eden W, Hoffman T, Verhoef J, Snippe H.
    Infect Immun; 1995 Mar 02; 63(3):961-8. PubMed ID: 7532630
    [Abstract] [Full Text] [Related]

  • 27. Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescents.
    Baxter R, Reisinger K, Block SL, Percell S, Odrljin T, Dull PM, Smolenov I.
    Pediatr Infect Dis J; 2014 Nov 02; 33(11):1169-76. PubMed ID: 24911896
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 02; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [Abstract] [Full Text] [Related]

  • 29. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
    Lieberman JM, Chiu SS, Wong VK, Partidge S, Chang SJ, Chiu CY, Gheesling LL, Carlone GM, Ward JI.
    JAMA; 1996 May 15; 275(19):1499-503. PubMed ID: 8622225
    [Abstract] [Full Text] [Related]

  • 30. A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial.
    Block SL, Szenborn L, Daly W, Jackowska T, D'Agostino D, Han L, Dull PM, Smolenov I.
    Vaccine; 2015 May 15; 33(21):2500-10. PubMed ID: 25795256
    [Abstract] [Full Text] [Related]

  • 31. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.
    McCool TL, Harding CV, Greenspan NS, Schreiber JR.
    Infect Immun; 1999 Sep 15; 67(9):4862-9. PubMed ID: 10456942
    [Abstract] [Full Text] [Related]

  • 32. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C, Poolman J, Boutriau D.
    Vaccine; 2007 Dec 12; 25(51):8487-99. PubMed ID: 17996996
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants.
    Klein NP, Reisinger KS, Johnston W, Odrljin T, Gill CJ, Bedell L, Dull P.
    Pediatr Infect Dis J; 2012 Jan 12; 31(1):64-71. PubMed ID: 22094635
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.
    Richmond P, Borrow R, Goldblatt D, Findlow J, Martin S, Morris R, Cartwright K, Miller E.
    J Infect Dis; 2001 Jan 01; 183(1):160-3. PubMed ID: 11078484
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.